nidНефрология и диализNephrology and Dialysis1680-44222618-9801Российское диализное обществоnid-2885Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESВирусные инфекции и трансплантация почки (Обзор литературы, часть II)Viral infections and renal transplantationПрокопенкоЕ. И.ProkopenkoE. I.linkor@moscow.portal.ruБудниковаН. Е.BoudnikovaN. E.noemail@neicon.ruМОНИКИ им. М.Ф. Владимирского, г. МоскваRussian Federation20032706202553200206Copyright © Прокопенко Е.И., Будникова Н.Е., 20252025Прокопенко Е.И., Будникова Н.Е.Prokopenko E.I., Boudnikova N.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephro.ru/jour/article/view/2885

В настоящее время известно несколько вирусов гепатита (A, B, C, D, E, G и др.), и число открытых вирусов продолжает расти. Однако в клинической трансплантологии наибольшее значение имеют 2 вируса: вирус гепатита B (HBV) и вирус гепатита C (HCV). В нашей стране распространенность вирусных гепатитов среди пациентов диализных центров и реципиентов почечного трансплантата достаточно высока [2, 3].

вирусытрансплантация почкииммуносупрессияReferencesВатазин А.В., Молочков В.А., Казанцева И.А. и др. Саркома Капоши у больных после трансплантации почки (опыт одного центра). Нефрология и диализ 2001; 1 (2): 86-89.Ватазин А.В., Молочков В.А., Казанцева И.А. и др. Саркома Капоши у больных после трансплантации почки (опыт одного центра). Нефрология и диализ 2001; 1 (2): 86-89.Зубкин М.Л., Селькова Е.П., Стаханова В.М. и др. Гепатит B в центрах гемодиализа Москвы: клинико-эпидемиологическая характеристика. Нефрология и диализ 2001; 3 (4): 442-447.Зубкин М.Л., Селькова Е.П., Стаханова В.М. и др. Гепатит B в центрах гемодиализа Москвы: клинико-эпидемиологическая характеристика. Нефрология и диализ 2001; 3 (4): 442-447.Иванова И.П. Трансплантация почки и гепатиты: особенности диагностики, лечения и профилактики у больных хронической почечной недостаточностью: Автореф. дисс. … канд. мед. наук. 1998; 32.Иванова И.П. Трансплантация почки и гепатиты: особенности диагностики, лечения и профилактики у больных хронической почечной недостаточностью: Автореф. дисс. … канд. мед. наук. 1998; 32.Майер К.-П. Гепатит и последствия гепатита. М.: Гэотар Медицина 1999: 423.Майер К.-П. Гепатит и последствия гепатита. М.: Гэотар Медицина 1999: 423.Суханов А.В. Полиомавирусная нефропатия трансплантата. Нефрология и диализ 2001; 3 (4): 411-413.Суханов А.В. Полиомавирусная нефропатия трансплантата. Нефрология и диализ 2001; 3 (4): 411-413.Шмарина Н.В., Тарабарко Н.В., Ржевская О.Н. и др. Оценка влияния рекомбинантного интерлейкина-1-бета у больных с терминальной стадией ХПН в лечении вирусных гепатитов B и C до трансплантации почки на течение раннего послеоперационного периода. Вестник трансплантологии и искусственных органов. 2003; 1: 24-27.Шмарина Н.В., Тарабарко Н.В., Ржевская О.Н. и др. Оценка влияния рекомбинантного интерлейкина-1-бета у больных с терминальной стадией ХПН в лечении вирусных гепатитов B и C до трансплантации почки на течение раннего послеоперационного периода. Вестник трансплантологии и искусственных органов. 2003; 1: 24-27.Ahsan N., Holman M.J., Gocke C.D. et al. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation. Clin Transplant 1997; 11 (4): 265-270.Ahsan N., Holman M.J., Gocke C.D. et al. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation. Clin Transplant 1997; 11 (4): 265-270.Ali M., Light G., Barhyte D. et al. Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation. Transplantation 1998; 66: 1694-1697.Ali M., Light G., Barhyte D. et al. Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation. Transplantation 1998; 66: 1694-1697.Baid S., Pascual M., Williams W.W. Jr. et al. Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol 1999; 10 (1): 146-153.Baid S., Pascual M., Williams W.W. Jr. et al. Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol 1999; 10 (1): 146-153.Batty D.S. Jr., Swanson S.J., Kirk A.D. et al. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant 2001 Jul; 1 (2): 179-184.Batty D.S. Jr., Swanson S.J., Kirk A.D. et al. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant 2001 Jul; 1 (2): 179-184.Berthoux P., Dejean C., Cecillon S. et al. High prevalence of hepatitis G virus (HGV) infection in renal transplantation. Nephrol Dial Transplant 1998; 13 (11): 2909-2013.Berthoux P., Dejean C., Cecillon S. et al. High prevalence of hepatitis G virus (HGV) infection in renal transplantation. Nephrol Dial Transplant 1998; 13 (11): 2909-2013.Berthoux P., Laurent B., Cecillon S., Berthoux F. Membranoproliferative glomerulonephritis with subendothelial deposits (type 1) associated with hepatitis G virus infection in a renal transplant recipient. Am J Nephrol 1999; 19 (4): 513-518.Berthoux P., Laurent B., Cecillon S., Berthoux F. Membranoproliferative glomerulonephritis with subendothelial deposits (type 1) associated with hepatitis G virus infection in a renal transplant recipient. Am J Nephrol 1999; 19 (4): 513-518.Bertoux F.C., Broyet C., Alamartine E. et al. HBs antigen positive organ donors and anti-HCV positive organ donors in renal transplantation. In: Touraine J.L. et al., eds. Transplantation and Clinical Immunology XXIII. Elsevier Science Publishers BV: 1991.Bertoux F.C., Broyet C., Alamartine E. et al. HBs antigen positive organ donors and anti-HCV positive organ donors in renal transplantation. In: Touraine J.L. et al., eds. Transplantation and Clinical Immunology XXIII. Elsevier Science Publishers BV: 1991.Besisik F., Sever M.S., Dincer D. et al. Serial measurements of serum transaminases in renal transplant recipients with chronic hepatitis C: do they reflect disease severity? Clin Transplant 2000; 14 (6): 529-532.Besisik F., Sever M.S., Dincer D. et al. Serial measurements of serum transaminases in renal transplant recipients with chronic hepatitis C: do they reflect disease severity? Clin Transplant 2000; 14 (6): 529-532.Breitenfeldt M.K., Rasenack J., Berthold H. et al. Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transplant 2002; 16 (2): 130-136.Breitenfeldt M.K., Rasenack J., Berthold H. et al. Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transplant 2002; 16 (2): 130-136.Campistol J.M., Esforzado N., Andres A. et al. Problematica y resultados del transplante renal con donnates HBsAg o VHC positivos. Nefrologia 1998; 18: 78-81.Campistol J.M., Esforzado N., Andres A. et al. Problematica y resultados del transplante renal con donnates HBsAg o VHC positivos. Nefrologia 1998; 18: 78-81.Campistol J.M., Esforzado N., Andres A. et al. Resultados del transplante renal utilizando rinones de donantes hepatitis C positivos y hepatitis B positiva. Nefrologia 1998; 18: 60-64.Campistol J.M., Esforzado N., Andres A. et al. Resultados del transplante renal utilizando rinones de donantes hepatitis C positivos y hepatitis B positiva. Nefrologia 1998; 18: 60-64.Choi S.H., Chang S.P., Won J.C. et al. A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection. Scand J Infect Dis 2002; 34 (1): 71-75.Choi S.H., Chang S.P., Won J.C. et al. A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection. Scand J Infect Dis 2002; 34 (1): 71-75.Cruzado J.M., Carrera M., Torras J., Grinyo J.M. Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant 2001; 1 (2): 171-178.Cruzado J.M., Carrera M., Torras J., Grinyo J.M. Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant 2001; 1 (2): 171-178.Dalekos G.N., Zervou E., Elisaf M. et al. Antibodies to hepatitis E virus among several populations in Greece: increased prevalence in an hemodialysis unit. Transfusion 1998; 38 (6): 589-595.Dalekos G.N., Zervou E., Elisaf M. et al. Antibodies to hepatitis E virus among several populations in Greece: increased prevalence in an hemodialysis unit. Transfusion 1998; 38 (6): 589-595.De Filippi F., Lampertico P., Soffredini R. et al. High prevalence, low pathogenicity of hepatitis G virus in kidney transplant recipients. Dig Liver Dis 2001; 33 (6): 477-479.De Filippi F., Lampertico P., Soffredini R. et al. High prevalence, low pathogenicity of hepatitis G virus in kidney transplant recipients. Dig Liver Dis 2001; 33 (6): 477-479.Delladetsima J.K., Makris F., Psichogiou M. et al. Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection. Liver 2001; 2; 1 (2): 81-88.Delladetsima J.K., Makris F., Psichogiou M. et al. Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection. Liver 2001; 2; 1 (2): 81-88.Diamantis I., Vafiadis I., Voskaridou E. et al. Genotype distribution of hepatitis C virus infection in Greece: correlation with different risk factors and response to interferon therapy. Eur J Gastroenterol Hepatol 1998; 10 (1): 75-79.Diamantis I., Vafiadis I., Voskaridou E. et al. Genotype distribution of hepatitis C virus infection in Greece: correlation with different risk factors and response to interferon therapy. Eur J Gastroenterol Hepatol 1998; 10 (1): 75-79.Fishman J.A., Rubin R.H. Medical progress: Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741-1751.Fishman J.A., Rubin R.H. Medical progress: Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741-1751.Fontaine H., Thiers V., Chretien Y. et al. HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients. Transplantation 2000; 69 (10): 2090-2094.Fontaine H., Thiers V., Chretien Y. et al. HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients. Transplantation 2000; 69 (10): 2090-2094.Fornarion S., Pol S., Legendre C. et al. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation 1996; 62: 297-299.Fornarion S., Pol S., Legendre C. et al. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation 1996; 62: 297-299.Gentil M.A., Luna E., Rodriguez-Algarra G. et al. Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C. Nephrol Dial Transplant 2002; 17 (5): 887-891.Gentil M.A., Luna E., Rodriguez-Algarra G. et al. Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C. Nephrol Dial Transplant 2002; 17 (5): 887-891.Goffin E., Pirson Y., van Ypersele de Strihou C. Implications of chronic hepatitis B or hepatitis C infection for renal transplant candidates. Nephrol Dial Transplant 1995; 10: 88-92.Goffin E., Pirson Y., van Ypersele de Strihou C. Implications of chronic hepatitis B or hepatitis C infection for renal transplant candidates. Nephrol Dial Transplant 1995; 10: 88-92.Hanafusa T., Ichikawa Y., Kishikawa H. et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998; 66: 471-476.Hanafusa T., Ichikawa Y., Kishikawa H. et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998; 66: 471-476.Hanrotel C., Toupance O., Lavaud S. et al. Virological and histological responses to one year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C. Nephron 2001; 88 (2): 120-126.Hanrotel C., Toupance O., Lavaud S. et al. Virological and histological responses to one year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C. Nephron 2001; 88 (2): 120-126.Huraib S., Iqbal A., Tanimu D., Abdullah A. Sustained virological and histological response with pretransplant interferon therapy in renal transplant patients with chronic viral hepatitis C. Am J Nephrol 2001; 21 (6): 435-440.Huraib S., Iqbal A., Tanimu D., Abdullah A. Sustained virological and histological response with pretransplant interferon therapy in renal transplant patients with chronic viral hepatitis C. Am J Nephrol 2001; 21 (6): 435-440.Ichikawa Y., Kyo M., Hanafusa T. et al. A 20-year case study of a kidney transplant recipient with chronic active hepatitis C: clinical course and successful treatment for late acute rejection induced by interferon therapy. Transplantation 1998; 65 (1): 134-138.Ichikawa Y., Kyo M., Hanafusa T. et al. A 20-year case study of a kidney transplant recipient with chronic active hepatitis C: clinical course and successful treatment for late acute rejection induced by interferon therapy. Transplantation 1998; 65 (1): 134-138.Isaacson A.H., Bhardwaj B., Qian K. et al. Hepatitis G virus infection in renal transplant recipients. J Viral Hepat 1999; 6 (2): 151-160.Isaacson A.H., Bhardwaj B., Qian K. et al. Hepatitis G virus infection in renal transplant recipients. J Viral Hepat 1999; 6 (2): 151-160.Izopet J., Rostaing L., Sandres K. et al. Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients. J Infect Dis 2000; 181 (3): 852-858.Izopet J., Rostaing L., Sandres K. et al. Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients. J Infect Dis 2000; 181 (3): 852-858.Jeong H.J., Choi K.H., Chon C.Y. et al. Membranoproliferative glomerulonephritis associated with HCV infection in native kidneys and renal allograft. J Korean Med Sci 1998; 13 (6): 670-675.Jeong H.J., Choi K.H., Chon C.Y. et al. Membranoproliferative glomerulonephritis associated with HCV infection in native kidneys and renal allograft. J Korean Med Sci 1998; 13 (6): 670-675.Jung Y.O., Lee Y.S., Yang W.S. et al. Treatment of chronic hepatitis B with lamivudine in renal transplant recipients. Transplantation 1998; 66 (6): 733-737.Jung Y.O., Lee Y.S., Yang W.S. et al. Treatment of chronic hepatitis B with lamivudine in renal transplant recipients. Transplantation 1998; 66 (6): 733-737.Kasiske B., Ramos E.L., Gaston R.S. et al. The evaluation of renal transplant candidates: clinical practice guidelines. J Am Soc Nephrol 1995; 6: 1-34.Kasiske B., Ramos E.L., Gaston R.S. et al. The evaluation of renal transplant candidates: clinical practice guidelines. J Am Soc Nephrol 1995; 6: 1-34.Kletzmayr J., Watschinger B., Muller C. et al. Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients. Transplantation 2000; 70 (9): 1404-1407.Kletzmayr J., Watschinger B., Muller C. et al. Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients. Transplantation 2000; 70 (9): 1404-1407.Knoll G.A., Tankersley M.R., Lee J.Y. et al. The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients. Am J Kid Dis 1997; 29: 608-614.Knoll G.A., Tankersley M.R., Lee J.Y. et al. The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients. Am J Kid Dis 1997; 29: 608-614.Lamproye A., Delwaide J., Vaira D. et al. Prevalence of hepatitis G virus in a haemodialysis unit. Acta Gastroenterol Belg 1999; 62 (1): 13-15.Lamproye A., Delwaide J., Vaira D. et al. Prevalence of hepatitis G virus in a haemodialysis unit. Acta Gastroenterol Belg 1999; 62 (1): 13-15.Lee H.K., Yoon G.S., Min K.S. et al. Fibrosing cholestatic hepatitis: a report of three cases. J Korean Med Sci 2000; 15 (1): 111-114.Lee H.K., Yoon G.S., Min K.S. et al. Fibrosing cholestatic hepatitis: a report of three cases. J Korean Med Sci 2000; 15 (1): 111-114.Lee P.C., Hung C.J., Lin Y.J. et al. A role for chronic parvovirus B19 infection in liver dysfunction in renal transplant recipients? Transplantation 2002; 73 (10): 1635-1639.Lee P.C., Hung C.J., Lin Y.J. et al. A role for chronic parvovirus B19 infection in liver dysfunction in renal transplant recipients? Transplantation 2002; 73 (10): 1635-1639.Lee W.C., Wu M.J., Cheng C.H. et al. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Am J Kidney Dis 2001; 38 (5): 1074-1081.Lee W.C., Wu M.J., Cheng C.H. et al. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Am J Kidney Dis 2001; 38 (5): 1074-1081.Lui S.L., Luk W.K., Cheung C.Y. et al. Nosocomial outbreak of parvovirus B19 infection in a renal transplant unit. Transplantation 2001; 71 (1): 59-64.Lui S.L., Luk W.K., Cheung C.Y. et al. Nosocomial outbreak of parvovirus B19 infection in a renal transplant unit. Transplantation 2001; 71 (1): 59-64.Martin P., Carter D., Fabrizi F. et al. Histopathological features of hepatitis C in renal transplant candidates. Transplantation 2000; 69 (7): 1479-1484.Martin P., Carter D., Fabrizi F. et al. Histopathological features of hepatitis C in renal transplant candidates. Transplantation 2000; 69 (7): 1479-1484.Mathurin P., Mouquet C., Poynard T. et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29 (1): 257-263.Mathurin P., Mouquet C., Poynard T. et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29 (1): 257-263.Molmenti E.P., Jain A.B., Shapiro R. et al. Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection. Transplantation 2001; 71 (2): 267-271.Molmenti E.P., Jain A.B., Shapiro R. et al. Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection. Transplantation 2001; 71 (2): 267-271.Morales J., Campistol J., Castellano G. et al. Transplantations of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int 1995; 47: 236-240.Morales J., Campistol J., Castellano G. et al. Transplantations of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int 1995; 47: 236-240.Morales J.M., Campistol J.M., Andres A., Rodicio J.L. Hepatitis C virus and renal transplantation. Curr Opin Nephrol Hypertens 1998; 7: 177-183.Morales J.M., Campistol J.M., Andres A., Rodicio J.L. Hepatitis C virus and renal transplantation. Curr Opin Nephrol Hypertens 1998; 7: 177-183.Morales J.M., Pascual-Capdevila J., Campistol J.M. et al. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation 1997; 63 (11): 1634-1639.Morales J.M., Pascual-Capdevila J., Campistol J.M. et al. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation 1997; 63 (11): 1634-1639.Moudgil A., Shidban H., Nast C.C. et al. Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin. Transplantation 1997; 64 (12): 1847-1850.Moudgil A., Shidban H., Nast C.C. et al. Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin. Transplantation 1997; 64 (12): 1847-1850.Munos de Bastillo E., Ibarrola C., Andres A. et al. Hepatitis-B-related fibrosing cholestatic hepatitis after renal transplantation with acute renal graft failure following interferon-alfa therapy. Nephrol Dial Transplant 1998; 13: 1574-1576.Munos de Bastillo E., Ibarrola C., Andres A. et al. Hepatitis-B-related fibrosing cholestatic hepatitis after renal transplantation with acute renal graft failure following interferon-alfa therapy. Nephrol Dial Transplant 1998; 13: 1574-1576.Munoz de Bustillo E., Ibarrola C., Colina F. et al. Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant patients. J Am Soc Neplirol 1998; 9: 1109-1113.Munoz de Bustillo E., Ibarrola C., Colina F. et al. Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant patients. J Am Soc Neplirol 1998; 9: 1109-1113.Murer L., Zacchello G., Bianchi D. et al. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol 2000; 11 (6): 1132-1137.Murer L., Zacchello G., Bianchi D. et al. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol 2000; 11 (6): 1132-1137.Ok E., Unsal A., Celik A. et al. Clinicopathological features of rapidly progressive hepatitis C virus infection in HCV antibody negative renal transplant recipients. Nephrol Dial Transplant 1998; 13 (12): 3103-3107.Ok E., Unsal A., Celik A. et al. Clinicopathological features of rapidly progressive hepatitis C virus infection in HCV antibody negative renal transplant recipients. Nephrol Dial Transplant 1998; 13 (12): 3103-3107.Pamidi S., Friedman K., Kampalath B. et al. Human parvovirus B19 infection presenting as persistent anemia in renal transplant recipients. Transplantation 2000; 69 (12): 2666-2269.Pamidi S., Friedman K., Kampalath B. et al. Human parvovirus B19 infection presenting as persistent anemia in renal transplant recipients. Transplantation 2000; 69 (12): 2666-2269.Park S.K., Yang W.S., Lee Y.S. et al. Outcome of renal transplantation in hepatitis B surface antigen-positive patients after introduction of lamivudine. Nephrol Dial Transplant 2001; 16 (11): 2222-2228.Park S.K., Yang W.S., Lee Y.S. et al. Outcome of renal transplantation in hepatitis B surface antigen-positive patients after introduction of lamivudine. Nephrol Dial Transplant 2001; 16 (11): 2222-2228.Pereira B.J., Wright T.L., Schmid C.H., Levey A.S. A controlled study of hepatitis C transmission by organ transplantation. Lancet 1995; 345: 484-487.Pereira B.J., Wright T.L., Schmid C.H., Levey A.S. A controlled study of hepatitis C transmission by organ transplantation. Lancet 1995; 345: 484-487.Peters M.G., Singer G., Howard T. et al. Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin. Transplantation 1999; 68 (12): 1912-1914.Peters M.G., Singer G., Howard T. et al. Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin. Transplantation 1999; 68 (12): 1912-1914.Pol S., Debure A., Degott C. et al. Chronic hepatitis in kidney allograft recipients. Lancet 1990; 335: 878-880.Pol S., Debure A., Degott C. et al. Chronic hepatitis in kidney allograft recipients. Lancet 1990; 335: 878-880.Pol S., Romeo R., Zins B. et al. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int 1993; 44: 1097-1100.Pol S., Romeo R., Zins B. et al. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int 1993; 44: 1097-1100.Post A.B., Hricik D.E., Sterling R.K. et al. Resolution of hepatitis B viremia in a renal transplant recipient treated with alpha-2b interferon. Nephron 1998; 79 (4): 469-471.Post A.B., Hricik D.E., Sterling R.K. et al. Resolution of hepatitis B viremia in a renal transplant recipient treated with alpha-2b interferon. Nephron 1998; 79 (4): 469-471.Preikschat P., Gunther S., Reinhold S. et al. Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients. Hepatology 2002; 35 (2): 466-477.Preikschat P., Gunther S., Reinhold S. et al. Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients. Hepatology 2002; 35 (2): 466-477.Puchhammer-Stockl E., Mandl C.W., Kletzmayr J. et al. Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapy. J Infect Dis 2000; 181 (6): 2063-2066.Puchhammer-Stockl E., Mandl C.W., Kletzmayr J. et al. Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapy. J Infect Dis 2000; 181 (6): 2063-2066.Rao K.V., Anderson W.R., Kasiske B.L., Dahl D.C. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 1993; 94: 241-250.Rao K.V., Anderson W.R., Kasiske B.L., Dahl D.C. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 1993; 94: 241-250.Rao K.V., Ma J. Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients. Transplantation 1996; 62: 1765-1769.Rao K.V., Ma J. Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients. Transplantation 1996; 62: 1765-1769.Rostaing L., Izopet J., Arnaud C. et al. Long-term impact of superinfection by hepatitis G virus in hepatitis C virus-positive renal transplant patients. Transplantation 1999; 67 (4): 556-560.Rostaing L., Izopet J., Arnaud C. et al. Long-term impact of superinfection by hepatitis G virus in hepatitis C virus-positive renal transplant patients. Transplantation 1999; 67 (4): 556-560.Rostaing L., Izopet J., Baron E. et al. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 1995; 59: 1426-1431.Rostaing L., Izopet J., Baron E. et al. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 1995; 59: 1426-1431.Rostaing L., Izopet J., Cisterne J.M. et al. Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features. Transplantation 1998; 65 (7): 930-936.Rostaing L., Izopet J., Cisterne J.M. et al. Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features. Transplantation 1998; 65 (7): 930-936.Rostaing L., Izopet J., Sandres K. et al. Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil. Transplantation 2000; 69 (5): 991-994.Rostaing L., Izopet J., Sandres K. et al. Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil. Transplantation 2000; 69 (5): 991-994.Rostaing L., Modesto A., Baron E. et al. Acute renal failure in kidney transplant patients treated with interferon alfa 2b for chronic hepatitis C. Nephron 1996; 74: 512-516.Rostaing L., Modesto A., Baron E. et al. Acute renal failure in kidney transplant patients treated with interferon alfa 2b for chronic hepatitis C. Nephron 1996; 74: 512-516.Santos F.R., Haiashi A.R., Araujo M.R. et al. Lamivudine therapy for hepatitis B in renal transplantation. Braz J Med Biol Res 2002; 35 (2): 199-203.Santos F.R., Haiashi A.R., Araujo M.R. et al. Lamivudine therapy for hepatitis B in renal transplantation. Braz J Med Biol Res 2002; 35 (2): 199-203.Stark K., Meyer C.G., Tacke M. Hepatitis G virus RNA and hepatitis G virus antibodies in renal transplant recipients: prevalence and risk factors. Transplantation 1997; 64 (4): 608-612.Stark K., Meyer C.G., Tacke M. Hepatitis G virus RNA and hepatitis G virus antibodies in renal transplant recipients: prevalence and risk factors. Transplantation 1997; 64 (4): 608-612.Tang S., Ho S.K., Moniri K. et al. Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant. Transplantation 2002; 73 (1): 148-151.Tang S., Ho S.K., Moniri K. et al. Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant. Transplantation 2002; 73 (1): 148-151.Van Duijnhoven E.M., Christiaans M.H., Boots J.M. et al. A late episode of post-transplant diabetes mellitus during active hepatitis C infection in a renal allograft recipient using tacrolimus. Am J Kidney Dis 2002; 40 (1): 195-201.Van Duijnhoven E.M., Christiaans M.H., Boots J.M. et al. A late episode of post-transplant diabetes mellitus during active hepatitis C infection in a renal allograft recipient using tacrolimus. Am J Kidney Dis 2002; 40 (1): 195-201.Vosnides G.G. Hepatitis C in renal transplantation. Kidney Int 1997; 52: 843-861.Vosnides G.G. Hepatitis C in renal transplantation. Kidney Int 1997; 52: 843-861.Wong T.Y., Chan P.K., Leung C.B. et al. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. Am J Kidney Dis 1999; 34 (6): 1132-1136.Wong T.Y., Chan P.K., Leung C.B. et al. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. Am J Kidney Dis 1999; 34 (6): 1132-1136.Yokosuka O., Ikeuchi T., Kanda T. et al. The prevalence of TT virus infection in renal transplant recipients in Brazil. Transplantation 2000; 70 (8): 1194-1197.Yokosuka O., Ikeuchi T., Kanda T. et al. The prevalence of TT virus infection in renal transplant recipients in Brazil. Transplantation 2000; 70 (8): 1194-1197.Zylberberg H., Carnot F., Mamzer M.F. et al. Hepatitis C virus related fibrosing cholestatic hepatitis after renal transplantation. Transplantation 1997; 63: 158-160.Zylberberg H., Carnot F., Mamzer M.F. et al. Hepatitis C virus related fibrosing cholestatic hepatitis after renal transplantation. Transplantation 1997; 63: 158-160.Zylberberg H., Nalpas B., Carnot F. et al. Severe evolution of chronic hepatitis C in renal transplantation: a case control study. Nephrol Dial Transplant 2002; 17 (1): 129-133.Zylberberg H., Nalpas B., Carnot F. et al. Severe evolution of chronic hepatitis C in renal transplantation: a case control study. Nephrol Dial Transplant 2002; 17 (1): 129-133.

The authors declare that there are no conflicts of interest present.